BUZZ — OPKO jumps on sale of select assets to Labcorp for up to $872 mln

* Shares of OPKO Health rise 31.4% to $1.80 premarket * Labcorp buys select laboratory testing businesses and over 80 patient centers from OPKO Health for $722 million in cash * The deal includes up to an additional $150 million milestone payment tied to revenue from a prostate cancer test * Labcorp acquires the proprietary 4Kscore prostate cancer test to expand specialized diagnostic access nationwide * Companies did not provide an expected closing date * Evercore ISI analysts view the deal as "a complementary tuck-in that adds specialty capabilities and regional density" to support Labcorp's expansion into higher-growth testing areas * As of last close, OPK up 8.7% YTD (Reporting by Kamal Choudhury in Bengaluru) ((Kamal.Choudhury@thomsonreuters.com;)